The Enterprise Value as of November 2024 (TTM) for Cyclo Therapeutics, Inc. (CYTH) is 20.10M

According to Cyclo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.10M. This represents a change of -36.13% compared to the average of 31.47M of the last 4 quarters.

Cyclo Therapeutics, Inc. (CYTH) Historical Enterprise Value (quarterly & annually)

How has CYTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Cyclo Therapeutics, Inc. over the last ten years is 23.79M. The current 20.10M Enterprise Value has changed 8.35% with respect to the historical average. Over the past ten years (40 quarters), CYTH's Enterprise Value was at its highest in in the December 2018 quarter at 67.57M. The Enterprise Value was at its lowest in in the December 2021 quarter at 7.61M.

Cyclo Therapeutics, Inc. (CYTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cyclo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cyclo Therapeutics, Inc. (CYTH) Average Enterprise Value

How has CYTH Enterprise Value performed in the past?

The current Enterprise Value of Cyclo Therapeutics, Inc. (CYTH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Cyclo Therapeutics, Inc. (CYTH) Enterprise Value vs. Peers

How is CYTH’s Enterprise Value compared to its peers?

Cyclo Therapeutics, Inc.’s Enterprise Value is greater than Athenex, Inc. (9.07M), less than MedMen Enterprises Inc. (385.18M), less than Lifecore Biomedical, Inc. (400.55M), greater than Lucy Scientific Discovery Inc. (2.06M), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Agile Therapeutics, Inc. (7.87M), less than Alpha Teknova, Inc. (415.19M), greater than Petros Pharmaceuticals, Inc. (6.06M), less than Phibro Animal Health Corporation (1.20B), greater than SOHM, Inc. (3.22M), less than Silver Spike Investment Corp. (33.56M), less than Eagle Pharmaceuticals, Inc. (24.78M), less than Intra-Cellular Therapies, Inc. (8.64B), less than Ironwood Pharmaceuticals, Inc. (677.16M), less than Amneal Pharmaceuticals, Inc. (6.31B), less than Aquestive Therapeutics, Inc. (374.75M), less than Assertio Holdings, Inc. (91.56M), greater than AcelRx Pharmaceuticals, Inc. (1.19M),

Build a custom stock screener for Cyclo Therapeutics, Inc. (CYTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclo Therapeutics, Inc. (CYTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.